Amgen Inc. (AMGN) Wednesday reported a 50 percent surge in third-quarter profit, driven largely by sales of arthritis drug Enbrel, and osteoporosis treatments Xgeva and Prolia. Both earnings and sales for the quarter trumped Wall Street estimates.
Forex – financial instrument.Forex news
Amgen Inc. (AMGN) Wednesday reported a 50 percent surge in third-quarter profit, driven largely by sales of arthritis drug Enbrel, and osteoporosis treatments Xgeva and Prolia. Both earnings and sales for the quarter trumped Wall Street estimates.